The prevalence of neuropathy, a common complication of diabetes, was determined in diabetic patients recruited from 109 outpatient diabetes clinics in Italy.Neuropathy was diagnosed using the Diabetic Neuropathy Index (DNI), a standardized examination developed for use in the outpatient setting. A total of 8,757 diabetic patients were studied, 51.2\% men and 48.8\% women, with average and median ages of 56 and 58 years, respectively.Of the 8,757 patients, 32.3\% had neuropathy, defined as a positive score of > 2 points on the DNI. A total of 2,033 (49.6\% men and 50.4\% women) were administered the Diabetic Neuropathy Score (DNS), the second component of the screening program, by a neurologist. This component consists of a quantitative neurological examination and nerve conduction studies that together provide a summated score. A total of 335 patients (16.5\%) were not neuropathic, and 395 (19.4\%) had borderline, 453 (22.3\%) mild, 592 (29.1\%) moderate, and 258 (12.7\%) severe neuropathy. The concordance between a positive score on the DNI and a DNS indicating neuropathy was 83.5\%. The severity of neuropathy increased with both age and disease duration. Of patients with neuropathy, 64.1\% had an average age between 58 and 59 years with a disease duration between 12.4 +/- 8.4 years (mild neuropathy) and 15.6 +/- 9.7 years (severe neuropathy).Neuropathy is a common complication of diabetes and, in this study, was present in 32.3\% of all patients. An increased awareness of the high prevalence of neuropathy can lead to early therapeutic intervention and possible prevention of later neuropathic complications, such as infection and foot ulcers.

A multicenter study on the prevalence of diabetic neuropathy in Italy. Italian Diabetic Neuropathy Committee.

CUCINOTTA, Domenico Maria;GIRLANDA, Paolo;
1997-01-01

Abstract

The prevalence of neuropathy, a common complication of diabetes, was determined in diabetic patients recruited from 109 outpatient diabetes clinics in Italy.Neuropathy was diagnosed using the Diabetic Neuropathy Index (DNI), a standardized examination developed for use in the outpatient setting. A total of 8,757 diabetic patients were studied, 51.2\% men and 48.8\% women, with average and median ages of 56 and 58 years, respectively.Of the 8,757 patients, 32.3\% had neuropathy, defined as a positive score of > 2 points on the DNI. A total of 2,033 (49.6\% men and 50.4\% women) were administered the Diabetic Neuropathy Score (DNS), the second component of the screening program, by a neurologist. This component consists of a quantitative neurological examination and nerve conduction studies that together provide a summated score. A total of 335 patients (16.5\%) were not neuropathic, and 395 (19.4\%) had borderline, 453 (22.3\%) mild, 592 (29.1\%) moderate, and 258 (12.7\%) severe neuropathy. The concordance between a positive score on the DNI and a DNS indicating neuropathy was 83.5\%. The severity of neuropathy increased with both age and disease duration. Of patients with neuropathy, 64.1\% had an average age between 58 and 59 years with a disease duration between 12.4 +/- 8.4 years (mild neuropathy) and 15.6 +/- 9.7 years (severe neuropathy).Neuropathy is a common complication of diabetes and, in this study, was present in 32.3\% of all patients. An increased awareness of the high prevalence of neuropathy can lead to early therapeutic intervention and possible prevention of later neuropathic complications, such as infection and foot ulcers.
1997
File in questo prodotto:
Non ci sono file associati a questo prodotto.
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11570/1943228
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? 22
  • Scopus 152
  • ???jsp.display-item.citation.isi??? 132
social impact